These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26304136)

  • 21. Periodic paralysis in quarter horses: a sodium channel mutation disseminated by selective breeding.
    Rudolph JA; Spier SJ; Byrns G; Rojas CV; Bernoco D; Hoffman EP
    Nat Genet; 1992 Oct; 2(2):144-7. PubMed ID: 1338908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypokalemic periodic paralysis and ataxia--Ca channel disorders].
    Konishi T
    No To Shinkei; 1997 Dec; 49(12):1068-78. PubMed ID: 9453037
    [No Abstract]   [Full Text] [Related]  

  • 23. SCN5A-related dilated cardiomyopathy: what do we know?
    Amin AS
    Heart Rhythm; 2014 Aug; 11(8):1454-5. PubMed ID: 24879950
    [No Abstract]   [Full Text] [Related]  

  • 24. Human disease hyperkalemic periodic paralysis is due to mutation in sodium channel alpha-subunit gene.
    Kumar S
    Indian J Exp Biol; 1991 May; 29(5):499. PubMed ID: 1655643
    [No Abstract]   [Full Text] [Related]  

  • 25. Anatomo-electrographic aspects in familial periodic paralysis.
    Arseni C; Carp N; Călcăianu G; Constantinescu AI; Ghiţescu M; Petrovici I; Poboran C
    Confin Neurol; 1971; 33(3):163-73. PubMed ID: 5117605
    [No Abstract]   [Full Text] [Related]  

  • 26. [Neuromuscular hereditary channelopathies: non-dystrophic myotonias, paramyotonias and periodic paralysis].
    Ruggieri VL; Arberas CL
    Rev Neurol; 2002 Jan 16-31; 34(2):150-6. PubMed ID: 11988910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of mutations in KCNQ1, KCNH2, and SCN5A in an unselected national cohort of young sudden unexplained death cases.
    Winkel BG; Larsen MK; Berge KE; Leren TP; Nissen PH; Olesen MS; Hollegaard MV; Jespersen T; Yuan L; Nielsen N; Haunsø S; Svendsen JH; Wang Y; Kristensen IB; Jensen HK; Tfelt-Hansen J; Banner J
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1092-8. PubMed ID: 22882672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal anaesthesia for familial hypokalaemic periodic paralysis.
    Stoneham MD; Moody RA
    Eur J Anaesthesiol; 1993 Sep; 10(5):375-7. PubMed ID: 11767430
    [No Abstract]   [Full Text] [Related]  

  • 29. Sodium channel defects in myotonia and periodic paralysis.
    Cannon SC
    Annu Rev Neurosci; 1996; 19():141-64. PubMed ID: 8833439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and mechanisms of action of novel NaV1.5 channel mutations associated with Brugada syndrome.
    Calloe K; Refaat MM; Grubb S; Wojciak J; Campagna J; Thomsen NM; Nussbaum RL; Scheinman MM; Schmitt N
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):177-84. PubMed ID: 23424222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exercise test on the patients with normokalaemic periodic paralysis from a Chinese family with a mutation in the SCN4A gene.
    Feng Y; Zhang Y; Liu ZL; Zhang CD
    Chin Med J (Engl); 2008 Oct; 121(19):1915-9. PubMed ID: 19080124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis.
    Rojas CV; Wang JZ; Schwartz LS; Hoffman EP; Powell BR; Brown RH
    Nature; 1991 Dec; 354(6352):387-9. PubMed ID: 1659668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial periodic paralysis.
    Gordon N
    Dev Med Child Neurol; 1973 Jun; 15(3):363-4. PubMed ID: 4718690
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful treatment of periodic paralysis with coenzyme Q10: two case reports.
    Da Y; Lei L; Jurkat-Rott K; Lehmann-Horn F
    Acta Myol; 2016 Oct; 35(2):107-108. PubMed ID: 28344441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Periodic paralysis mutation MiRP2-R83H in controls: Interpretations and general recommendation.
    Jurkat-Rott K; Lehmann-Horn F
    Neurology; 2004 Mar; 62(6):1012-5. PubMed ID: 15037716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p.Y1449C SCN5A mutation associated with overlap disorder comprising conduction disease, Brugada syndrome, and atrial flutter.
    Hothi SS; Ara F; Timperley J
    J Cardiovasc Electrophysiol; 2015 Jan; 26(1):93-7. PubMed ID: 24903439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Periodic palsies and myotonias are ion channel diseases].
    Fontaine B; Fardeau M
    Rev Neurol (Paris); 1996 Oct; 152(10):579-86. PubMed ID: 9033950
    [No Abstract]   [Full Text] [Related]  

  • 39. A study of the SCN5A gene in a cohort of 76 patients with Brugada syndrome.
    García-Molina E; Lacunza J; Ruiz-Espejo F; Sabater M; García-Alberola A; Gimeno JR; Cañizares F; García A; Martínez P; Valdés M; Tovar I
    Clin Genet; 2013 Jun; 83(6):530-8. PubMed ID: 22984773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias.
    Swan H; Amarouch MY; Leinonen J; Marjamaa A; Kucera JP; Laitinen-Forsblom PJ; Lahtinen AM; Palotie A; Kontula K; Toivonen L; Abriel H; Widen E
    Circ Cardiovasc Genet; 2014 Dec; 7(6):771-81. PubMed ID: 25210054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.